SU 14813 : a novel multiple receptor tyrosine kinase inhibitor with potent antiangiogenic and antitumor activity
暂无分享，去创建一个
C. Liang | J. Cherrington | S. Vasile | D. Hu-Lowe | J. Sukbuntherng | W. Zhong | D. Mendel | A. Laird | J. Haznedar | Jeffrey H. Chen | Xueyan Wang | T. Vojkovský | C. Yang | S. Patyna | A. O'Farrell | M. Grazzini | HuipingGuan | Huckova Dana